This month, the Alzheimer’s Policy Working Group (APWG) released a new policy paper, Solving America’s Alzheimer’s Challenge, laying out a clinician-driven roadmap to improve how the U.S. diagnoses and manages Alzheimer’s disease—starting in primary care, where most patients first raise concerns. The paper reflects the real-world experience of frontline physicians Read more…
In a recent RealClearMarkets column, Charles Sauer examines the growing push to impose “most favored nation” (MFN) drug pricing through legislation expanding access to home infusion therapy—and explains why importing foreign-style price controls would ultimately hurt patients, not help them. Home infusion therapy allows millions of Americans with cancer, heart Read more…
The Market Institute has joined a broad coalition of national and state-based organizations urging the Missouri General Assembly to support Governor Mike Kehoe’s Missouri Promise—a responsible, trigger-based plan to phase out the state individual income tax and modernize Missouri’s outdated tax system. Missouri-Letter Missouri’s current income tax structure dates back Read more…
Elon Musk is learning that in Europe, defending free speech comes at a steep price. In a recent RealClearMarkets column, Charles Sauer examines the European Union’s decision to fine X $140 million under its Digital Services Act (DSA) — a move that looks far less like consumer protection and far Read more…
Alzheimer’s disease is no longer just a medical challenge. It is a looming fiscal crisis—and one the United States is dangerously unprepared to confront. In a recent column published in The Capitalist, Charles Sauer argued that policymakers urgently need to recognize Alzheimer’s as an economic ticking time bomb. Without a Read more…
As Charles Sauer explains in a recent column for RealClearMarkets, the backlash against Netflix’s proposed acquisition of Warner Bros. reflects today’s reflexive antitrust panic—not the realities of competition in the entertainment marketplace. Critics on both the left and right have rushed to portray the deal as a threat to consumers, Read more…
iRobot, the Massachusetts-based maker of the Roomba robot vacuum, has filed for bankruptcy. While competition from newer, innovative rivals played a role, iRobot’s collapse cannot be understood without examining the role of regulators and politicians who blocked the company’s best chance to survive. As Market Institute Senior Fellow Norm Singleton Read more…
House Republicans are searching for ways to advance conservative health care reform while securing the votes needed to pass their package. There is already a solution on the table—one that delivers real savings without expanding government control. In a letter to House leadership, Market Institute President Charles Sauer urged Congress Read more…
Rising beef prices have become a political talking point, but blaming “Big Beef” won’t make groceries cheaper. As Charles Sauer explains in a recent article originally published in RealClearMarkets, government crackdowns on meatpackers risk repeating the same antitrust mistakes that have already failed to lower prices elsewhere in the economy. Read more…
As Congress debates its next major healthcare package, one reform stands out for its ability to lower costs, strengthen competition, and protect patient choice: Site Neutrality. Today, federal policy pays hospital-owned facilities far more than independent physicians for the exact same service—a distortion that fuels consolidation, drives up prices, and Read more…